CANIHELMIN PLUS
CANIHELMIN PLUS
Suspended
- Praziquantel
- Pyrantel embonate
- Febantel
Product identification
Medicine name:
CANIHELMIN PLUS
CANIHELMIN PLUS 50 mg/144mg/150mg COMPRIMIDOS PARA PERROS
Active substance:
- Praziquantel
- Pyrantel embonate
- Febantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel50.00milligram(s)1.00Tablet
-
Pyrantel embonate144.00milligram(s)1.00Tablet
-
Febantel150.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Suspended
Authorised in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Genera d.d.
Marketing authorisation date:
Manufacturing sites for batch release:
- Genera d.d.
Responsible authority:
- The Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 3423 ESP
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0245/001
Concerned member states:
-
Bulgaria
-
Czechia
-
Romania
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 22/12/2023
Spanish (PDF)
Published on: 27/02/2024
Combined File of all Documents
English (PDF)
Download Published on: 21/11/2022
How useful was this page?: